Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Previous clinical trials showing the benefit of continuous glucose monitoring (CGM) in the management of type 1 diabetes predominantly have included adults using insulin pumps, even though the majority of adults with type 1 diabetes administer insulin by injection.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JAMA

Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Electronic): 1538-3598

ISSN (Print): 0098-7484

Publication date (Electronic): January 24 2017

Volume: 317

Issue: 4

Affiliations

[1 ] Jaeb Center for Health Research, Tampa, Florida.

[2 ] Oregon Health & Science University, Portland.

[3 ] Park Nicollet Institute, International Diabetes Center, St Louis Park, Minnesota.

[4 ] Diabetes & Glandular Disease Clinic, San Antonio, Texas.

[5 ] Division of Endocrinology, Henry Ford Medical Center, Detroit, Michigan.

[6 ] Washington University in St Louis, St Louis, Missouri.

[7 ] Behavioral Diabetes Institute, San Diego, California.

[8 ] Joslin Diabetes Center, Boston, Massachusetts.

[9 ] Dexcom Inc, San Diego, California.

Article

Publisher Item ID: 2598770

DOI: 10.1001/jama.2016.19975

PubMed ID: 28118453

SO-VID: 3ee09c28-0580-4bf5-a0e3-84c96f08c2e8

History

Data availability:

Comments

Comment on this article

scite_

Cited by 397

See all cited by

- Version 1